Slowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing CLN2 is a research paper published in Science Translational Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 74 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: TR000457
National Institute of Neurological Disorders and Stroke
Grant: NS061848
National Institute of Neurological Disorders and Stroke
Grant: NS065768
Nathan’s Battle
Grant: N/A
NCATS NIH HHS
Grant: UL1 TR002384
NINDS NIH HHS
Grant: R01 NS061848
NINDS NIH HHS
Grant: U54 NS065768
NCATS NIH HHS
Grant: UL1 TR000457
National Institutes of Health
Grant: 2U54NS065768-11
Lysosomal Disease Network
National Institutes of Health
Grant: 5R01NS061848-03
Gene Therapy for Batten Disease Using AAVrh.10 Expressing Human CLN2 cDNA
National Institutes of Health
Grant: 3UL1TR000457-08S1
Clinical and Translational Science Center
FWCI
4.31
Citation Percentile
1.0%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 4 of Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression
Additional file 4 of Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression